My primary interest is identification of genetic determinants of drug response through modern methods aimed at addressing pharmacogenomics research and translating that information into new diagnostics and treatment strategies at point-of-care.
I am a physician-scientist with training in pulmonary medicine, genetics, and epidemiology. My research and academic interests center on identifying disease risk factors specific to racial groups, most especially those related to asthma and drug response. I am engaged in a new, international field...
My research seeks to understand the contribution of genetic variation to drug toxicity, to identify genetic biomarkers that can be used to guide effective use of drugs in the treatment of cancer and HIV, and to use genetics to unravel the molecular basis of drug-induced toxicity.
